Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Bcl-2 is the prototypical member of a large family of apoptosis-regulating proteins, consisting of blockers and promoters of cell death. The three-dimensional structure of a Bcl-2 homologue, Bcl-X L , suggests striking similarity to the pore-forming domains of diphtheria toxin and the bacterial colicins, prompting exploration of whether Bcl-2 is capable of forming pores in lipid membranes. Using chloride efflux from KCl-loaded unilamellar lipid vesicles as an assay, purified recombinant Bcl-2 protein exhibited pore-forming activity with properties similar to those of the bacterial toxins, diphtheria toxin, and colicins, i.e., dependence on low pH and acidic lipid membranes. In contrast, a mutant of Bcl-2 lacking the two core hydrophobic α-helices (helices 5 and 6), predicted to be required for membrane insertion and channel formation, produced only nonspecific effects. In planar lipid bilayers, where detection of single channels is possible, Bcl-2 formed discrete ion-conducting, cation-selective channels, whereas the Bcl-2 (Δh5, 6) mutant did not. The most frequent conductance observed (18 ± 2 pS in 0.5 M KCl at pH 7.4) is consistent with a four-helix bundle structure arising from Bcl-2 dimers. However, larger channel conductances (41 ± 2 pS and 90 ± 10 pS) also were detected with progressively lower occurrence, implying the step-wise formation of larger oligomers of Bcl-2 in membranes. These findings thus provide biophysical evidence that Bcl-2 forms channels in lipid membranes, suggesting a novel function for this antiapoptotic protein.

Bibliography

Schendel, S. L., Xie, Z., Montal, M. O., Matsuyama, S., Montal, M., & Reed, J. C. (1997). Channel formation by antiapoptotic protein Bcl-2. Proceedings of the National Academy of Sciences, 94(10), 5113–5118.

Authors 6
  1. Sharon L. Schendel (first)
  2. Zhihua Xie (additional)
  3. Myrta Oblatt Montal (additional)
  4. Shigemi Matsuyama (additional)
  5. Mauricio Montal (additional)
  6. John C. Reed (additional)
References 51 Referenced 464
  1. 10.1083/jcb.124.1.1
  2. 10.1182/blood.V88.2.386.bloodjournal882386
  3. 10.1074/jbc.270.20.11962
  4. 10.1073/pnas.92.17.7834
  5. 10.1038/369321a0
  6. J C Reed Behring Institute Mitteilungen, eds P H Krammer, S Nagata (Behring Institute Mitteilungen, Marburg) 97, 72–100 (1996). / Behring Institute Mitteilungen by Reed J C (1996)
  7. 10.1126/science.7878464
  8. S Krajewski, S Tanaka, S Takayama, M J Schibler, W Fenton, J C Reed Cancer Res 53, 4701–4714 (1993). / Cancer Res by Krajewski S (1993)
  9. T Lithgow, R van Driel, J F Bertram, A Strasser Cell Growth Differ 3, 411–417 (1994). / Cell Growth Differ by Lithgow T (1994)
  10. 10.1016/S0021-9258(18)53280-4
  11. 10.1073/pnas.91.14.6569
  12. C M Marin, A Fernandez, R J Bick, S Brisbay, L M Buja, M Snuggs, D J McConkey, A C von Eschenbach, M J Keating, T J McDonnell Oncogene 12, 2259–2266 (1996). / Oncogene by Marin C M (1996)
  13. A N Murphy, D E Bredesen, G Cotopassi, E Wang, G Fiskum Neurobiology 93, 9893–9898 (1996). / Neurobiology by Murphy A N (1996)
  14. 10.1073/pnas.91.13.5878
  15. 10.1038/381335a0
  16. 10.1073/pnas.80.12.3706
  17. 10.1146/annurev.bb.24.060195.003143
  18. 10.1111/j.1574-6968.1992.tb05889.x
  19. 10.1073/pnas.82.5.1386
  20. 10.1073/pnas.78.1.172
  21. 10.1038/298669a0
  22. 10.1073/pnas.78.8.4950
  23. 10.1016/0022-2836(92)90550-4
  24. 10.1007/BF01995700
  25. 10.1126/science.8382373
  26. 10.1016/S0021-9258(17)31678-2
  27. 10.1016/S0006-3495(96)79847-8
  28. 10.1146/annurev.bb.24.060195.000335
  29. 10.1073/pnas.87.18.6929
  30. 10.1016/S0021-9258(18)82375-4
  31. 10.1038/361309a0
  32. 10.1128/MCB.16.11.6494
  33. 10.1007/978-1-4757-1361-9_8
  34. 10.1073/pnas.91.4.1495
  35. 10.1083/jcb.126.4.1059
  36. 10.1016/S0021-9258(18)47934-3
  37. 10.1016/0092-8674(93)90508-N
  38. 10.1073/pnas.91.20.9238
  39. 10.1016/0014-5793(93)80599-P
  40. 10.1016/S0959-440X(96)80115-1
  41. D de Jong, F A Prins, D Y Mason, J C Reed, G B van Ommen, P M Kluin Cancer Res 54, 256–260 (1994). / Cancer Res by de Jong D (1994)
  42. 10.1038/348334a0
  43. 10.1016/S0021-9258(17)37542-7
  44. 10.1016/S0021-9258(17)39425-5
  45. 10.1016/S0021-9258(18)82376-6
  46. T Hennet, G Bertoni, C Richter, E Peterhans Cancer Res 53, 1456–1460 (1993). / Cancer Res by Hennet T (1993)
  47. 10.1016/S0092-8674(00)80085-9
  48. 10.1084/jem.184.4.1331
  49. 10.1084/jem.183.4.1533
  50. 10.1038/385353a0
  51. 10.1042/bj3180849
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:43 a.m.)
Deposited 3 years, 4 months ago (April 13, 2022, 2:50 p.m.)
Indexed 3 weeks, 3 days ago (Aug. 7, 2025, 5:05 p.m.)
Issued 28 years, 3 months ago (May 13, 1997)
Published 28 years, 3 months ago (May 13, 1997)
Published Online 28 years, 3 months ago (May 13, 1997)
Published Print 28 years, 3 months ago (May 13, 1997)
Funders 0

None

@article{Schendel_1997, title={Channel formation by antiapoptotic protein Bcl-2}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.10.5113}, DOI={10.1073/pnas.94.10.5113}, number={10}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Schendel, Sharon L. and Xie, Zhihua and Montal, Myrta Oblatt and Matsuyama, Shigemi and Montal, Mauricio and Reed, John C.}, year={1997}, month=may, pages={5113–5118} }